FDA report urges stronger warnings for acetaminophen

05/27/2009 | Bloomberg

An FDA working group released a report urging reduced doses of drugs containing acetaminophen and warnings about liver injury linked to such drugs. The report, which also advises against using acetaminophen in nonprescription combination products such as Tylenol Cold, will be discussed by FDA advisory panels June 29 and 30.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY